Second-line nivolumab in relapsed small-cell lung cancer: CheckMate 331
Spigel, D.R., Vicente, D., Ciuleanu, T.E., Gettinger, S., Peters, S., Horn, L., Audigier-Valette, C., Pardo Aranda, N., Juan-Vidal, O., Cheng, Y., Zhang, H., Shi, M., Luft, A., Wolf, J., Antonia, S., Nakagawa, K., Fairchild, J., Baudelet, C., Pandya, D., Doshi, P., Chang, H., Reck, M.
Published in Annals of oncology (01.05.2021)
Published in Annals of oncology (01.05.2021)
Get full text
Journal Article
Multiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S., Sanso, M., Hernando-Calvo, A., Callejo, A., Pardo Aranda, N., Navarro Mendivil, A., Martinez, A., Remon, J., Miquel, J.M., Rodriguez, G., Monton, V., Villacampa, G., Dienstmann, R., Vivancos, A., Felip Font, E.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
Analysis of expression of PTEN/PI3K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
Cedrés, S., Ponce-Aix, S., Pardo-Aranda, N., Navarro-Mendivil, A., Martinez-Marti, A., Zugazagoitia, J., Sansano, I., Montoro, M.A., Enguita, A., Felip, E.
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Get full text
Journal Article
1637P Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT)
Cedres Perez, S.M., Valdivia, A., Assaf, J.D., Iranzo Gomez, P., Callejo, A., Pardo Aranda, N., Navarro Mendivil, A.F., Martinez-Marti, A., Molina, G., Navarro, V., Gonzalo, J., Soleda, M., Frigola, J., Carbonell, C., Amat, R., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
2193P Real-world evidence of the impact of immunotherapy (IT) on overall survival (OS) of patients (p) with malignant pleural mesothelioma (MPM) adjusted for tumor histology
Perez, S.M. Cedres, Valdivia, A.A., Pastrana, J.D. Assaf, Gomez, P. Iranzo, Perez, A. Callejo, Aranda, N. Pardo, Mendivil, A.F. Navarro, Martinez-Marti, A., Priano, I., Hermida, J.M. Ucha, Garcia-Galea, E., Gonzalo, J., Caro, R., Carbonell, C., Amat, R., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1733P Analysis of chemotherapy (Ct) efficacy according to histology in malignant pleural mesothelioma (MPM) patients (p)
Cedres, S., Assaf, J.D., Gomez, P. Iranzo, Perez, A. Callejo, Aranda, N. Pardo, Navarro, A., Martinez-Marti, A., Castaneda, D.H. Marmolejo, Aron, M.A. Rezqallah, Pedrola, A., Gonzalo, J., Frigola, J., Carbonell, C., Amat, R., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.09.2021)
Published in Annals of oncology (01.09.2021)
Get full text
Journal Article
Analysis of expression of PTEN/PI3 K pathway and programmed cell death ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)
Cedrés, S, Ponce-Aix, S, Pardo, N, Navarro-Mendivil, A, Martinez-Marti, A, Zugazagoitia, J, Sansano, I, Montoro, M.A, Enguita, A, Felip, E
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Published in Lung cancer (Amsterdam, Netherlands) (01.06.2016)
Get full text
Journal Article
1806PDMultiple primary cancers (MPC) in a series of lung cancer (LC) patient: Incidence and outcome
Cedres Perez, S, Sanso, M, Hernando-Calvo, A, Callejo, A, Pardo Aranda, N, Navarro Mendivil, A, Martinez, A, Remon, J, Miquel, J M, Rodriguez, G, Monton, V, Villacampa, G, Dienstmann, R, Vivancos, A, Felip Font, E
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
P1.16-05 Incidence and Outcome of Multiple Primary Cancers (MPC) in a Series of Lung Cancer (LC) Patients
Cedres, S., Hernando-Calvo, A., Iranzo, P., Callejo, A., Aranda, N. Pardo, Navarro, A., Martinez-Marti, A., Assaf, J.D., Miquel, J.M., Rodriguez, G., Monton, V., Pedrola, A., Viaplana, C., Carbonell, C., Sanso, M., Dienstmann, R., Amat, R., Vivancos, A., Felip, E.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article
166P Impact of immunotherapy (IT) on overall survival (OS) of patients with malignant pleural mesothelioma (MPM) adjusted for tumor histology
Perez, S.M. Cedres, Valdivia, A.A., Pastrana, J.D. Assaf, Gomez, P. Iranzo, Aranda, N. Pardo, Mendivil, A.F. Navarro, Martinez-Marti, A., Prina, M. Meazza, Garcia-Galea, E., Gonzalo, J., Dienstmann, R., Felip, E.
Published in ESMO open (01.03.2024)
Published in ESMO open (01.03.2024)
Get full text
Journal Article
KRAS mutations(m) in lung adenocarcinoma (AC) patients(p) receiving standard chemotherapy (ch) and immune checkpoint inhibitors (i-CI): Impact of KRAS clonality and coexisting TP53m
Aranda, N. Pardo, Ruiz, F., Marti, A. Martinez, Cedres, S., Mendivil, A. Navarro, fuente, Idela, de Castro, A. Martinez, Vivancos, A., Dienstmann, R., Felip, E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
Cedres, S., Aranda, N. Pardo, de Castro, A. Martinez, Mendivil, A. Navarro, Marti, A. Martinez, Ortiz, C., Racca, F., Vilaro, M., Carbonell, L., Piera, A., fuente, Idela, Felip, E.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article